Evidence map›Paper›PMID 23394681›Full record

ArticleBiochemistry2013

Anti-idiotypic monobodies derived from a fibronectin scaffold.

Mark A Sullivan, Lauren R Brooks, Philip Weidenborner, William Domm, Jonelle Mattiacio, Qingfu Xu, Michael Tiberio, Timothy Wentworth, James Kobie, Peter Bryk and 4 more

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. An Engineered Pathway for Production of Terminally SialylatedFrontiers in bioengineering and biotechnology · 2020
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis.Annual review of analytical chemistry (Palo Alto, Calif.) · 2017
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Mark A SullivanDepartment of Microbiology and Immunology and ‡Department of Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York 14642, United States.
Lauren R Brooks
Philip Weidenborner
William Domm
Jonelle Mattiacio
Qingfu Xu
Michael Tiberio
Timothy Wentworth
James Kobie
Peter Bryk
Bo Zheng
Mary Murphy
Ignacio Sanz
Stephen Dewhurst
Rochester General Hospital · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Virology/Immunology CoreP30AI078498 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2008 to 2018
$14.6M
TRAINING PROGRAM IN ORAL SCIENCET32DE007202 · NIDCR · UNIVERSITY OF ROCHESTER · PI QUIVEY, ROBERT G · 1990 to 2010
$5.5M
Training in Cellular, Biochemical and Molecular SciencesT32GM068411 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2005 to 2019
$3.9M
A Model System for the Study of Human B-cell ToleranceR37AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2010 to 2019
$3.7M
Understanding the Generation of HIV Broadly Neutralizing AntibodiesR01AI084808 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2009 to 2013
$3.2M
Cellular Origins of HIV Broadly Neutralizing AntibodiesR21AI078459 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2008 to 2009
$535k
Use of Discontinuous Peptide Display for Generation of HIV Antigen MimicsR21AI087149 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2010 to 2011
$420k
NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI078498NIAID NIH HHS R01 AI084808NIAID NIH HHS R21 AI078459NIAID NIH HHS R21 AI087149NIAID NIH HHS R37 AI049660NIDCR NIH HHS T32 DE007202NIGMS NIH HHS T32 GM068411
6 · The paper itself

Abstract

Mimetics of conformational protein epitopes have broad applications but have been difficult to identify using conventional peptide phage display. The 10th type III domain of human fibronectin (FNfn10) has two extended, randomizable surface-exposed loops and might be more amenable to the identification of such mimetics. We therefore selected a library of FNfn10 clones, randomized in both loops (15 residues in all), for binding to monoclonal antibodies (mAbs) that recognize the HIV-1 envelope glycoprotein. Anti-idiotypic monobodies (αIMs) mimicking both "linear" epitopes (2F5 and 4E10 mAbs) and conformational epitopes (b12 and VRC01 mAbs) were generated. αIMs selected against 2F5 and 4E10 frequently displayed sequence homology to the corresponding linear native epitopes. In the case of b12 and VRC01, we expected that the two constrained loop domains of FNfn10 would both contribute to complex conformational interactions with target antibodies. However, mutagenesis studies revealed differences from this simple model. An αIM selected against b12 was found to bind its cognate antibody via only a few residues within the BC loop of FNfn10, with minimal contribution from the FG loop. Unexpectedly, this was sufficient to generate a protein that engaged its cognate antibody in a manner very similar to that of HIV-1 Env, and with a strong KD (43 nM). In contrast, an αIM selected against VRC01 engaged its cognate antibody in a manner that was dependent on both BC and FG loop sequences. Overall, these data suggest that the FNfn10 scaffold can be used to identify complex structures that mimic conformational protein epitopes.

Indexed as

Amino Acid SequenceAntibodies, Anti-IdiotypicAntibodies, MonoclonalBinding, CompetitiveBiomimetic MaterialsBroadly Neutralizing AntibodiesFibronectinsHIV-1HIV AntibodiesHumansModels, MolecularMutagenesis, Site-DirectedPeptide LibraryProtein Conformation2F5 monoclonal antibody4E10 monoclonal antibodyAntibodies, Anti-IdiotypicAntibodies, MonoclonalBroadly Neutralizing AntibodiesFibronectinsHIV AntibodiesPeptide Library

Identifiers

PMID23394681
PMCPMC4090420
OpenAlexW2050516344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.